ANRO · Alto Neuroscience, Inc.
$27.23
+0.16 (+0.59%)
At close · Jul 22
Market Cap
$955.61M
Shares
35.09M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$63.24M
-2.9%
FY2025
Diluted EPS
-$2.19
+12.4%
FY2025
Operating Cash Flow
-$51.77M
-9.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $55.94M | $45.62M | $47M | $30.29M | |
| $21.89M | $20.75M | $21.61M | $7.52M | |
| $576K | — | $502K | $373K | |
| $77.83M | $66.36M | $68.61M | $37.81M | |
| -$77.83M | -$66.36M | -$68.61M | -$37.81M | |
| $2.42M | $2.47M | $1.38M | $1.37M | |
| $6.34M | $6.6M | $8.85M | $2.35M | |
| $3.52M | $3.13M | $7.18M | $1.5M | |
| — | $0 | $0 | $0 | |
| -$74.31M | -$63.24M | -$61.43M | -$36.31M | |
| USD/shares | — | -$2.19 | -$2.50 | -$9.73 |
| USD/shares | — | -$2.19 | -$2.50 | -$9.73 |
| shares | — | 28.85M | 24.6M | 3.73M |
| shares | — | 28.85M | 24.6M | 3.73M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.58×
EV/EBIT
—
Biotechnology median 26.67×
P/E (TTM)
—
Biotechnology median 7.06×